131 related articles for article (PubMed ID: 31160779)
1. Insights into L-type heteromeric amino acid transporters.
Newstead S
Nat Struct Mol Biol; 2019 Jun; 26(6):395-396. PubMed ID: 31160779
[No Abstract] [Full Text] [Related]
2. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
Yan R; Zhao X; Lei J; Zhou Q
Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591
[TBL] [Abstract][Full Text] [Related]
3. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.
Lee Y; Wiriyasermkul P; Jin C; Quan L; Ohgaki R; Okuda S; Kusakizako T; Nishizawa T; Oda K; Ishitani R; Yokoyama T; Nakane T; Shirouzu M; Endou H; Nagamori S; Kanai Y; Nureki O
Nat Struct Mol Biol; 2019 Jun; 26(6):510-517. PubMed ID: 31160781
[TBL] [Abstract][Full Text] [Related]
4. The structure of the human 4F2hc-LAT1 heteromeric amino acid transporter.
Fotiadis D; Jeckelmann JM
Sci China Life Sci; 2019 Jun; 62(6):848-850. PubMed ID: 31076972
[No Abstract] [Full Text] [Related]
5. Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
Khunweeraphong N; Nagamori S; Wiriyasermkul P; Nishinaka Y; Wongthai P; Ohgaki R; Tanaka H; Tominaga H; Sakurai H; Kanai Y
J Pharmacol Sci; 2012; 119(4):368-80. PubMed ID: 22850614
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for substrate specificity of heteromeric transporters of neutral amino acids.
Rodriguez CF; Escudero-Bravo P; Díaz L; Bartoccioni P; García-Martín C; Gilabert JG; Boskovic J; Guallar V; Errasti-Murugarren E; Llorca O; Palacín M
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34848541
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a novel member of the heterodimeric amino acid transporter family presumed to be associated with an unknown heavy chain.
Chairoungdua A; Kanai Y; Matsuo H; Inatomi J; Kim DK; Endou H
J Biol Chem; 2001 Dec; 276(52):49390-9. PubMed ID: 11591708
[TBL] [Abstract][Full Text] [Related]
8. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
[TBL] [Abstract][Full Text] [Related]
9. LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM.
Chiduza GN; Johnson RM; Wright GSA; Antonyuk SV; Muench SP; Hasnain SS
Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):660-669. PubMed ID: 31282475
[TBL] [Abstract][Full Text] [Related]
10. CD98 increases renal epithelial cell proliferation by activating MAPKs.
Bulus N; Feral C; Pozzi A; Zent R
PLoS One; 2012; 7(6):e40026. PubMed ID: 22768207
[TBL] [Abstract][Full Text] [Related]
11. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Nachef M; Ali AK; Almutairi SM; Lee SH
Front Immunol; 2021; 12():624324. PubMed ID: 33953707
[TBL] [Abstract][Full Text] [Related]
12. Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc.
Rosell A; Meury M; Álvarez-Marimon E; Costa M; Pérez-Cano L; Zorzano A; Fernández-Recio J; Palacín M; Fotiadis D
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):2966-71. PubMed ID: 24516142
[TBL] [Abstract][Full Text] [Related]
13. Amino acids labeled with [99mTc(CO)3]+ and recognized by the L-type amino acid transporter LAT1.
Liu Y; Pak JK; Schmutz P; Bauwens M; Mertens J; Knight H; Alberto R
J Am Chem Soc; 2006 Dec; 128(50):15996-7. PubMed ID: 17165727
[TBL] [Abstract][Full Text] [Related]
14. Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
Jeckelmann JM; Fotiadis D
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795505
[TBL] [Abstract][Full Text] [Related]
15. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
[TBL] [Abstract][Full Text] [Related]
16. Detergent-induced stabilization and improved 3D map of the human heteromeric amino acid transporter 4F2hc-LAT2.
Meury M; Costa M; Harder D; Stauffer M; Jeckelmann JM; Brühlmann B; Rosell A; Ilgü H; Kovar K; Palacín M; Fotiadis D
PLoS One; 2014; 9(10):e109882. PubMed ID: 25299125
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H
Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859
[TBL] [Abstract][Full Text] [Related]
18. JPH203, an L-type amino acid transporter 1-selective compound, induces apoptosis of YD-38 human oral cancer cells.
Yun DW; Lee SA; Park MG; Kim JS; Yu SK; Park MR; Kim SG; Oh JS; Kim CS; Kim HJ; Kim JS; Chun HS; Kanai Y; Endou H; Wempe MF; Kim DK
J Pharmacol Sci; 2014; 124(2):208-17. PubMed ID: 24492461
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of two S-nitroso-L-cysteine transporters, which mediate movement of NO equivalents into vascular cells.
Li S; Whorton AR
Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1263-71. PubMed ID: 17092994
[TBL] [Abstract][Full Text] [Related]
20. Essential Roles of L-Type Amino Acid Transporter 1 in Syncytiotrophoblast Development by Presenting Fusogenic 4F2hc.
Ohgaki R; Ohmori T; Hara S; Nakagomi S; Kanai-Azuma M; Kaneda-Nakashima K; Okuda S; Nagamori S; Kanai Y
Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28320871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]